BIM
XBI icon

BlackRock Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BlackRock Investment Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,031
Closed -$135K – 3983
2016
Q3 		$135K Buy
2,031
+231
+13% +$14.3K ﹤0.01% 3260
2016
Q2 		$97K Buy
+1,800
New +$98.6K ﹤0.01% 3311

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Investment Management's XBI Position: Q4 2016 in Review

BlackRock Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2016, closing a stake of 2,031 shares — an estimated $135K sold.

BlackRock Investment Management first reported a position in XBI in Q2 2016 and held it in 2 quarters. The position peaked at $135K in Q3 2016. 274 funds tracked by Wall St. Rank hold XBI as of Q4 2016.

  • BlackRock Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 2,031 State Street SPDR S&P Biotech ETF shares in Q4 2016, an estimated $135K.
  • BlackRock Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 2 quarters.
  • BlackRock Investment Management's State Street SPDR S&P Biotech ETF position peaked at $135K in Q3 2016.
  • 274 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.